Evidence map›Paper›PMID 21248087›Full record

ArticleJournal of clinical microbiology2011

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan.

Seiichiro Fujisaki, Yoshiyuki Yokomaku, Teiichiro Shiino, Tomohiko Koibuchi, Junko Hattori, Shiro Ibe, Yasumasa Iwatani, Aikichi Iwamoto, Takuma Shirasaka, Motohiro Hamaguchi and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Is there any value to hepatitis B virus genotype analysis?Current gastroenterology reports · 2012
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors.

Seiichiro FujisakiDepartment of Infection and Immunology, Clinical Research Center, Nagoya Medical Center, 4-1-1 Sannomaru, Nakaku, Nagoya 4600001, Japan.
Yoshiyuki Yokomaku
Teiichiro Shiino
Tomohiko Koibuchi
Junko Hattori
Shiro Ibe
Yasumasa Iwatani
Aikichi Iwamoto
Takuma Shirasaka
Motohiro Hamaguchi
Wataru Sugiura

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major routes of hepatitis B virus (HBV) infection in Japan has been mother-to-child transmission (MTCT) and blood transfusion. However, HBV cases transmitted through sexual contact are increasing, especially among HIV-1-seropositive patients. To understand the molecular epidemiology of HBV in HBV/HIV-1 coinfection, we analyzed HBV genotypes and HIV-1 subtypes in HBV/HIV-1-coinfected patients at Nagoya Medical Center from 2003 to 2007. Among 394 HIV-1-infected Japanese men having sex with men (MSM) who were newly diagnosed during the study period, 31 (7.9%) tested positive for the hepatitis B virus surface antigen. HBV sequence analyses were successful in 26 cases, with 21 (80.7%) and 5 (19.3%) cases determined as genotypes A and C, respectively. Our finding that HBV genotype A was dominant in HIV-1-seropositive patients alerts clinicians to an alternative outbreak of HBV genotype A in the HIV-1-infected MSM population and a shift in HBV genotype from C to A in Japan. The narrow genetic diversity in genotype A cases suggests that genotype A has been recently introduced into the MSM population and that sexual contacts among MSM were more active than speculated from HIV-1 tree analyses. In addition, we found a lamivudine resistance mutation in one naïve case, suggesting a risk of drug-resistant HBV transmission. As genotype A infection has a higher risk than infection with other genotypes for individuals to become HBV carriers, prevention programs are urgently needed for the target population.

Indexed as

Disease OutbreaksDrug Resistance, ViralAdultAntiviral AgentsCluster AnalysisDNA, ViralFemaleGenetic VariationGenotypeHepatitis BHepatitis B virusHIV-1HIV InfectionsHumansJapanMaleAntiviral AgentsDNA, Viral

Identifiers

PMID21248087
PMCPMC3067677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.